The Food and Drug Administration will complete reviews of certain drugs more quickly, the agency’s commissioner announced on June 17.
FDA Commissioner Dr. Martin Makary said the new Commissioner’s National Priority Voucher program will help reduce the time the agency spends reviewing final applications for drugs.
“Through this pilot, companies will receive a decision within a month or two, as opposed to the typical 10 to 12 months,” Makary said in a video statement.
The program aims to streamline the process by convening experts from various FDA offices to conduct a review, rather than the standard process of sending an application to numerous offices, the FDA said. A team of doctors and scientists will pre-review the submitted information and hold a one-day meeting to go over it….